According to an article in CityBizList Boston, legendary Market Wizard Bruce Kovner has tripled his stake in Synta Pharmaceuticals ($SNTA), a company that is working on a promising anti-cancer drug called Ganetespib;

Billionaire Bruce Kovner has nearly tripled his holding in Synta Pharmaceuticals Corp. (Nasdaq: SNTA) to 25.40 percent worth $93.53 million, according to an SEC filing.

In June, Kovner owned 4.93 million shares, representing an 8.55 percent stake then valued at $23.86 million.

Part of Kovner’s stake is held through CxSynta LLC, the Kovner Investment Trust andDavid Ben-Ur, the chief investment officer of Caxton Alternative Management.

Here is a chart of $SNTA over the past year:

By applying comprehensive technical analysis here I can definitively tell you that the chart isn’t telling me anything, except that $SNTA acts like a typical pharma stock; lying around doing nothing and then suddenly becoming wildly volatile.

Point is though, when a billionaire trading titan like Kovner starts taking an increased interest in a company like this, it’s not a bad idea to keep it on your radar.

Read the Form 13G filing.

Read the full CityBizList Boston article.

Why not subscribe to bclund.com for free  Via E-mail or Via RSS and follow me on StockTwits and Twitter?

What bclund is, is the intersection of markets, trading, and life (with some punk rock, pop culture, and off-beat humor mixed in).  Check out “The Best Of bclund” to get started.